Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 3529149, 12 pages
http://dx.doi.org/10.1155/2016/3529149
Review Article

Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?

Departamento de Biología Celular y Desarrollo, Instituto de Fisiología Celular, UNAM, 04510 Mexico City, DF, Mexico

Received 19 July 2015; Accepted 11 October 2015

Academic Editor: Karina R. Gordillo

Copyright © 2016 Martha Lucinda Contreras-Zentella and Rolando Hernández-Muñoz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. L. Verrill, N. A. Pickard, and H. D. Gruemer, “Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability,” Clinical Chemistry, vol. 23, no. 12, pp. 2219–2225, 1997. View at Google Scholar
  2. E. Schmidt and F. W. Schmidt, “Release of enzymes from the liver,” Nature, vol. 213, no. 5081, pp. 1125–1126, 1967. View at Publisher · View at Google Scholar · View at Scopus
  3. A.-M. Batt and L. Ferrari, “Manifestations of chemically induced liver damage,” Clinical Chemistry, vol. 41, no. 12, pp. 1882–1887, 1995. View at Google Scholar · View at Scopus
  4. D. R. Dufour, J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff, “Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests,” Clinical Chemistry, vol. 46, no. 12, pp. 2027–2049, 2000. View at Google Scholar · View at Scopus
  5. H. G. Peltenburg, W. T. Hermens, G. M. Willems, J. G. Flendrig, and E. Schmidt, “Estimation of the fractional catabolic rate constants for the elimination of cytosolic liver enzymes from plasma,” Hepatology, vol. 10, no. 5, pp. 833–839, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Schmidt and F. W. Schmidt, “Aspekte der Enzym-Diagnostik,” Die Medizinische Welt, vol. 21, pp. 805–816, 1970. View at Google Scholar
  7. W. M. Frederiks, I. M. C. Vogels, and G. M. Fronik, “Plasma ornithine carbamyl transferase level as an indicator of ischaemic injury of rat liver,” Cell Biochemistry and Function, vol. 2, no. 4, pp. 217–220, 1984. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Van Waes and C. S. Lieber, “Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic,” British Medical Journal, vol. 2, no. 6101, pp. 1508–1510, 1977. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Nalpas, A. Vassault, S. Charpin, B. Lacour, and P. Berthelot, “Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit,” Hepatology, vol. 6, no. 4, pp. 608–614, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. D. K. Ingawale, S. K. Mandlik, and S. R. Naik, “Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion,” Environmental Toxicology and Pharmacology, vol. 37, no. 1, pp. 118–133, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Singla, S. K. Sharma, A. Mohan et al., “Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity,” Indian Journal of Medical Research, vol. 132, no. 7, pp. 81–86, 2010. View at Google Scholar · View at Scopus
  12. C. Gronhagen-Riska, P.-E. Hellstrom, and B. Froseth, “Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis,” American Review of Respiratory Disease, vol. 118, no. 3, pp. 461–466, 1978. View at Google Scholar · View at Scopus
  13. M. Den Brinker, F. W. N. M. Wit, P. M. E. Wertheim-van Dillen et al., “Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection,” AIDS, vol. 14, no. 18, pp. 2895–2902, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Lammert, S. Einarsson, C. Saha, A. Niklasson, E. Bjornsson, and N. Chalasani, “Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals,” Hepatology, vol. 47, no. 6, pp. 2003–2009, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Traversa, C. Bianchi, R. Da Cas, I. Abraha, F. Menniti-Ippolito, and M. Venegoni, “Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs,” British Medical Journal, vol. 327, no. 7405, pp. 18–22, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. T. Banks, H. J. Zimmerman, K. G. Ishak, and J. G. Harter, “Diclofenac-associated hepatotoxicity: analysis of 180 cases reported to the food and drug administration as adverse reactions,” Hepatology, vol. 22, no. 3, pp. 820–827, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. E. M. Tarazi, J. G. Harter, H. J. Zimmerman, K. G. Ishak, and R. A. Eaton, “Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration,” Gastroenterology, vol. 104, no. 2, pp. 569–574, 1993. View at Google Scholar · View at Scopus
  18. G. P. Aithal and C. P. Day, “Nonsteroidal anti-inflammatory drug-induced hepatotoxicity,” Clinics in Liver Disease, vol. 11, no. 3, pp. 563–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Somasundaram, G. Sigthorsson, R. J. Simpson et al., “Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat,” Alimentary Pharmacology & Therapeutics, vol. 14, no. 5, pp. 639–650, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. U. A. Boelsterli, M. R. Redinbo, and K. S. Saitta, “Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies,” Toxicological Sciences, vol. 131, no. 2, pp. 654–667, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Dongiovanni, Q. M. Anstee, and L. Valenti, “Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment,” Current Pharmaceutical Design, vol. 19, no. 29, pp. 5219–5238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. C. P. Day, “From fat to inflammation,” Gastroenterology, vol. 130, no. 1, pp. 207–210, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., “Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity,” Hepatology, vol. 40, no. 6, pp. 1387–1395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty liver disease: old questions and new insights,” Science, vol. 332, no. 6037, pp. 1519–1523, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. E. Lavine and J. B. Schwimmer, “Nonalcoholic fatty liver disease in the pediatric population,” Clinics in Liver Disease, vol. 8, no. 3, pp. 549–558, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. A. E. Feldstein, “Novel insights into the pathophysiology of nonalcoholic fatty liver disease,” Seminars in Liver Disease, vol. 30, no. 4, pp. 391–401, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Tilg, “The role of cytokines in non-alcoholic fatty liver disease,” Digestive Diseases, vol. 28, no. 1, pp. 179–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. G. S. Hotamisligil, “Endoplasmic reticulum stress and the inflammatory basis of metabolic disease,” Cell, vol. 140, no. 6, pp. 900–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. Hooper, L. A. Adams, and J. R. Burnett, “Genetic determinants of hepatic steatosis in man,” Journal of Lipid Research, vol. 52, no. 4, pp. 593–617, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Q. Starley, C. J. Calcagno, and S. A. Harrison, “Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection,” Hepatology, vol. 51, no. 5, pp. 1820–1832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. T. M. Donohue Jr., “Alcohol-induced steatosis in liver cells,” World Journal of Gastroenterology, vol. 13, no. 37, pp. 4974–4978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. K. Mantena, A. L. King, K. K. Andringa, H. B. Eccleston, and S. M. Bailey, “Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1259–1272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Liu, X. Wang, Z. Peng et al., “The effects of insulin pre-administration in mice exposed to ethanol: alleviating hepatic oxidative injury through anti-oxidative, anti-apoptotic activities and deteriorating hepatic steatosis through SRBEP-1c activation,” International Journal of Biological Sciences, vol. 11, no. 5, pp. 569–586, 2015. View at Publisher · View at Google Scholar
  34. M. You, M. Fischer, M. A. Deeg, and D. W. Crabb, “Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP),” The Journal of Biological Chemistry, vol. 277, no. 32, pp. 29342–29347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Shimomura, Y. Bashmakov, S. Ikemoto, J. D. Horton, M. S. Brown, and J. L. Goldstein, “Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 24, pp. 13656–13661, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Medina and R. Moreno-Otero, “Pathophysiological basis for antioxidant therapy in chronic liver disease,” Drugs, vol. 65, no. 17, pp. 2445–2461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. A. K. Tiwari, “Imbalance in antioxidant defence and human diseases: multiple approach of natural antioxidants therapy,” Current Science, vol. 81, no. 9, pp. 1179–1187, 2001. View at Google Scholar · View at Scopus
  38. S. R. Naik, V. N. Thakare, and S. R. Patil, “Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: evidence of its antioxidant property,” Experimental and Toxicologic Pathology, vol. 63, no. 5, pp. 419–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. M. A. Ibrahim, M. Kelleni, and A. Geddawy, “Nonalcoholic fatty liver disease: current and potential therapies,” Life Sciences, vol. 92, no. 2, pp. 114–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Ludwig, D. B. McGill, and K. D. Lindor, “Review: nonalcoholic steatohepatitis,” Journal of Gastroenterology and Hepatology, vol. 12, no. 5, pp. 398–403, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Morán-Ramos, A. Avila-Nava, A. R. Tovar, J. Pedraza-Chaverri, P. López-Romero, and N. Torres, “Opuntia ficus indica (nopal) attenuates hepatic steatosis and oxidative stress in obese Zucker (fa/fa) rats,” Journal of Nutrition, vol. 142, no. 11, pp. 1956–1963, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Carmiel-Haggai, A. I. Cederbaum, and N. Nieto, “A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats,” The FASEB Journal, vol. 19, no. 1, pp. 136–138, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Sancho, P. Martín-Sanz, and I. Fabregat, “Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway,” Free Radical Biology and Medicine, vol. 51, no. 9, pp. 1789–1798, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Savard, E. V. Tartaglione, R. Kuver et al., “Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis,” Hepatology, vol. 57, no. 1, pp. 81–92, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. Y. H. Paik and D. A. Brenner, “NADPH oxidase mediated oxidative stress in hepatic fibrogenesis,” The Korean Journal of Hepatology, vol. 17, no. 4, pp. 251–257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocrine Reviews, vol. 23, no. 5, pp. 599–622, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. W. Zhu, Q. Jia, Y. Wang, Y. Zhang, and M. Xia, “The anthocyanin cyanidin-3-O-β-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: involvement of a cAMP-PKA-dependent signaling pathway,” Free Radical Biology and Medicine, vol. 52, no. 2, pp. 314–327, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. I. Levin, J. Petrasek, and G. Szabo, “The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis,” Alcoholism: Clinical and Experimental Research, vol. 36, no. 8, pp. 1397–1406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. A. dela Peña, I. A. Leclercq, J. Williams, and G. C. Farrell, “NADPH oxidase is not an essential mediator of oxidative stress or liver injury in murine MCD diet-induced steatohepatitis,” Journal of Hepatology, vol. 46, no. 2, pp. 304–312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. J. X. Jiang, S. Venugopal, N. Serizawa et al., “Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in Vivo,” Gastroenterology, vol. 139, no. 4, pp. 1375–1384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. N. S. R. De Mochel, S. Seronello, S. H. Wang et al., “Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection,” Hepatology, vol. 52, no. 1, pp. 47–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Albano, “Alcohol, oxidative stress and free radical damage,” Proceedings of the Nutrition Society, vol. 65, no. 3, pp. 278–290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S.-J. Lee, S.-Y. Kim, and H. Min, “Effects of vitamin C and E supplementation on oxidative stress and liver toxicity in rats fed a low-fat ethanol diet,” Nutrition Research and Practice, vol. 7, no. 2, pp. 109–114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. G. L. Russo, M. Russo, and P. Ungaro, “AMP-activated protein kinase: a target for old drugs against diabetes and cancer,” Biochemical Pharmacology, vol. 86, no. 3, pp. 339–350, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. C. J. Bailey and R. C. Turner, “Metformin,” The New England Journal of Medicine, vol. 334, no. 9, pp. 574–579, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Nerstedt, A. Johansson, C. X. Andersson, E. Cansby, U. Smith, and M. Mahlapuu, “AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3),” Diabetologia, vol. 53, no. 11, pp. 2406–2416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. C. S. Park, B.-R. Bang, H.-S. Kwon et al., “Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase,” Biochemical Pharmacology, vol. 84, no. 12, pp. 1660–1670, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. Y. Kato, N. Koide, T. Komatsu et al., “Metformin attenuates production of nitric oxide in response to lipopolysaccharide by inhibiting MyD88-independent pathway,” Hormone and Metabolic Research, vol. 42, no. 9, pp. 632–636, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. A. Alhaider, H. M. Korashy, M. M. Sayed-Ahmed, M. Mobark, H. Kfoury, and M. A. Mansour, “Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression,” Chemico-Biological Interactions, vol. 192, no. 3, pp. 233–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. X. Hou, J. Song, X.-N. Li et al., “Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway,” Biochemical and Biophysical Research Communications, vol. 396, no. 2, pp. 199–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. I. Onaran, G. S. Guven, S. B. Ozdaş, G. Kanigur, and S. Vehid, “Metformin does not prevent DNA damage in lymphocytes despite its antioxidant properties against cumene hydroperoxide-induced oxidative stress,” Mutation Research—Genetic Toxicology and Environmental Mutagenesis, vol. 611, no. 1-2, pp. 1–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Yuan, L. Li, W. Zheng et al., “Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice,” International Immunopharmacology, vol. 12, no. 4, pp. 682–688, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Dai, M. Liu, Q. Ai et al., “Involvement of catalase in the protective benefits of metformin in mice with oxidative liver injury,” Chemico-Biological Interactions, vol. 216, no. 1, pp. 34–42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. I.-C. Lee, S.-H. Kim, H.-S. Baek et al., “The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats,” Food and Chemical Toxicology, vol. 63, pp. 174–185, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Lamlé, S. Marhenke, J. Borlak et al., “Nuclear factor-erythroid2-related factor 2 prevents alcohol-induced fulminant liver injury,” Gastroenterology, vol. 134, no. 4, pp. 1159–1168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. S. A. Reisman, I. I. Csanaky, L. M. Aleksunes, and C. D. Klaassen, “Altered disposition of acetaminophen in Nrf2-null and keap1-knockdown mice,” Toxicological Sciences, vol. 109, no. 1, pp. 31–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. N. R. Kitteringham, A. Abdullah, J. Walsh et al., “Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver,” Journal of Proteomics, vol. 73, no. 8, pp. 1612–1631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Yan, J. Dong, K. K. Sulik, and S.-Y. Chen, “Induction of the Nrf2-driven antioxidant response by tert-butylhydroquinone prevents ethanol-induced apoptosis in cranial neural crest cells,” Biochemical Pharmacology, vol. 80, no. 1, pp. 144–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. M. P. Valdecantos, P. L. Prieto-Hontoria, V. Pardo et al., “Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes,” Free Radical Biology and Medicine, vol. 84, pp. 263–278, 2015. View at Publisher · View at Google Scholar
  70. N. C. Bozkurt, E. Cakal, M. Sahin, E. C. Ozkaya, H. Firat, and T. Delibasi, “The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities,” Endocrine, vol. 41, no. 3, pp. 518–525, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Sharifi, R. Amani, E. Hajiani, and B. Cheraghian, “Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial,” Endocrine, vol. 47, no. 1, pp. 70–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Bunchorntavakul, T. Wootthananont, and A. Atsawarungruanqkit, “Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study,” Journal of the Medical Association of Thailand, vol. 97, supplement 11, pp. S31–S40, 2014. View at Google Scholar
  73. A. Reuben, “Hy's law,” Hepatology, vol. 39, no. 2, pp. 574–578, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. L. E. Johansson, U. Lindblad, C. A. Larsson, L. Råstam, and M. Ridderstråle, “Polymorphisms in the adiponutrin gene are associated with increased insulin secretion and obesity,” European Journal of Endocrinology, vol. 159, no. 5, pp. 577–583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. C. J. Weston, E. L. Shepherd, L. C. Claridge et al., “Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis,” Journal of Clinical Investigation, vol. 125, no. 2, pp. 501–520, 2015. View at Publisher · View at Google Scholar
  76. I. C. M. E. de Abreu, J. F. D. C. Guerra, R. R. Pereira et al., “Hypercholesterolemic diet induces hepatic steatosis and alterations in mRNA expression of NADPH oxidase in rat livers,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 58, no. 3, pp. 251–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. E. Grasselli, A. D. Compalati, A. Voci et al., “Altered oxidative stress/antioxidant status in blood of alcoholic subjects is associated with alcoholic liver disease,” Drug and Alcohol Dependence, vol. 143, no. 1, pp. 112–119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Luo, L. Xu, J. Li, and S. Zhao, “Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease,” European Journal of Gastroenterology and Hepatology, vol. 27, no. 3, pp. 193–199, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. S. J. Curtis, M. Mortiz, and P. J. Snodgrass, “Serum enzymes derived from liver cell fractions. I. The response to carbon Liver flow/mass controls enzyme release 231 tetrachloride intoxication in rats,” Gastroenterology, vol. 62, pp. 84–92, 1972. View at Google Scholar
  80. H. J. Zimmerman, Y. Kodera, and M. West, “Rate of increase in plasma levels of cytoplasmic and mitochondrial enzymes in experimental carbon tetrachloride hepatotoxicity,” The Journal of Laboratory and Clinical Medicine, vol. 66, no. 2, pp. 315–323, 1965. View at Google Scholar · View at Scopus
  81. B. D. Dinman and I. A. Bernstein, “Acute carbon tetrachloride hepatotoxicity. V. Enzymatic activity and structural concomitants during the regenerative phase,” Archives of Environmental Health, vol. 16, no. 6, pp. 777–784, 1968. View at Publisher · View at Google Scholar · View at Scopus
  82. G. Ruggiero, “Rate of release of cytoplasmic and mitochondrial enzymes from the isolated and perfused rat liver treated with phalloidin,” The Journal of Laboratory and Clinical Medicine, vol. 82, no. 5, pp. 695–703, 1973. View at Google Scholar · View at Scopus
  83. J. Kanta and F. Bartos, “Relationship of liver damage and liver regeneration after carbon tetrachloride treatment in rats,” Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University v Hradci Kralove, vol. 34, no. 3, pp. 237–242, 1991. View at Google Scholar · View at Scopus
  84. C. J. Fievet, M. P. Gigandet, and H. C. Ansel, “Hemolysis of erythrocytes by primary pharmacologic agents,” American Journal of Hospital Pharmacy, vol. 28, no. 12, pp. 961–966, 1971. View at Google Scholar · View at Scopus
  85. S. Miyake, “The mechanism of release of hepatic enzymes in various liver diseases. Altered activity ratios of GOT and GPT in serum and liver of patients with liver diseases,” Acta Medica Okayama, vol. 33, pp. 343–358, 1979. View at Google Scholar
  86. W. G. Guder, A. Habicht, J. Kleissl, U. Schmidt, and O. H. Wieland, “The diagnostic significance of liver cell inhomogeneity: serum enzymes in patients with central liver necrosis and the distribution of glutamate dehydrogenase in normal human liver,” Zeitschrift fur Klinische Chemie und Klinische Biochemie, vol. 13, no. 7, pp. 311–318, 1975. View at Google Scholar · View at Scopus
  87. G. K. Michalopoulos and M. C. DeFrances, “Liver regeneration,” Science, vol. 276, no. 5309, pp. 60–66, 1997. View at Publisher · View at Google Scholar · View at Scopus
  88. K. F. Aronsen, B. Ericsson, and B. Pihl, “Metabolic changes following major hepatic resection,” Annals of Surgery, vol. 169, no. 1, pp. 102–110, 1969. View at Publisher · View at Google Scholar · View at Scopus
  89. S. Bengmark, L. Engevik, and R. Olsson, “Changes in ornithine carbamoyl transferase activity in serum and in liver after partial hepatectomy in rats,” Scandinavian Journal of Gastroenterology, vol. 3, no. 3, pp. 264–266, 1968. View at Publisher · View at Google Scholar · View at Scopus
  90. O. Almersjö, S. Bengmark, L. O. Hafström, and R. Olsson, “Enzyme and function changes after extensive liver resection in man,” Annals of Surgery, vol. 169, no. 1, pp. 111–119, 1969. View at Publisher · View at Google Scholar · View at Scopus
  91. Y. Panis, D. M. McMullan, and J. C. Emond, “Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection,” Surgery, vol. 121, no. 2, pp. 142–149, 1997. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Díaz-Juárez, L. Rivera-Valerdi, D. E. Bernal-Cerrillo, and R. Hernández-Muñoz, “Predominance of released mitochondrial enzymes by partial hepatectomy-induced rat regenerating liver is controlled by hemodynamic changes and not related to mitochondrial damage,” Scandinavian Journal of Gastroenterology, vol. 41, no. 2, pp. 223–233, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. J. A. Morales-González, J. Gutiérrez-Salinas, L. Yánez, C. Villagómez-Rico, J. Badillo-Romero, and R. Hernández-Munoz, “Morphological and biochemical effects of a low ethanol dose on rat liver regeneration: role of route and timing of administration,” Digestive Diseases and Sciences, vol. 44, no. 10, pp. 1963–1974, 1999. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Hernández-Muñoz, L. Sánchez-Sevilla, A. Martínez-Gómez, and M. A. R. Dent, “Changes in mitochondrial adenine nucleotides and in permeability transition in two models of rat liver regeneration,” Hepatology, vol. 37, no. 4, pp. 842–851, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. M. Chachisvilis, Y.-L. Zhang, and J. A. Frangos, “G protein-coupled receptors sense fluid shear stress in endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 42, pp. 15463–15468, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. C. R. White and J. A. Frangos, “The shear stress of it all: the cell membrane and mechanochemical transduction,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 362, no. 1484, pp. 1459–1467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. N. Adamek, L. M. Coluccio, and M. A. Geeves, “Calcium sensitivity of the cross-bridge cycle of Myo1c, the adaptation motor in the inner ear,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 15, pp. 5710–5715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. H. Rubin and T. Koide, “Mutual potentiation by magnesium and calcium of growth in animal cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 1, pp. 168–172, 1976. View at Publisher · View at Google Scholar · View at Scopus
  99. J. F. Whitfield, A. L. Boynton, J. P. MacManus et al., “The roles of calcium and cyclic AMP in cell proliferation,” Annals of the New York Academy of Sciences, vol. 339, pp. 216–240, 1980. View at Publisher · View at Google Scholar · View at Scopus
  100. M. Y. Pahakis, J. R. Kosky, R. O. Dull, and J. M. Tarbell, “The role of endothelial glycocalyx components in mechanotransduction of fluid shear stress,” Biochemical and Biophysical Research Communications, vol. 355, no. 1, pp. 228–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Díaz-Juárez and R. Hernández-Muñoz, “The role of calcium and nitric oxide during liver enzyme release induced by increased physical forces as evidenced in partially hepatectomized rats,” Liver Transplantation, vol. 17, no. 3, pp. 334–343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  102. N. Fausto and E. M. Webber, “Control of liver growth,” Critical Reviews in Eukaryotic Gene Expression, vol. 3, no. 2, pp. 117–135, 1993. View at Google Scholar · View at Scopus
  103. I. Aguilar-Delfín, F. López-Barrera, and R. Hernández-Muñoz, “Selective enhancement of lipid peroxidation in plasma membrane in two experimental models of liver regeneration: partial hepatectomy and acute CCl4 administration,” Hepatology, vol. 24, no. 3, pp. 657–662, 1996. View at Publisher · View at Google Scholar · View at Scopus
  104. M. Greco, L. Moro, G. Pellecchia, S. Di Pede, and F. Guerrieri, “Release of matrix proteins from mitochondria to cytosol during the prereplicative phase of liver regeneration,” FEBS Letters, vol. 427, no. 2, pp. 179–182, 1998. View at Publisher · View at Google Scholar · View at Scopus
  105. I. Oikawa and P. M. Novikoff, “Catalase-negative peroxisomes: transient appearance in rat hepatocytes during liver regeneration after partial hepatectomy,” American Journal of Pathology, vol. 146, no. 3, pp. 673–687, 1995. View at Google Scholar · View at Scopus